An eHealth Psychosocial Intervention for Caregivers of Children With Cancer
1 other identifier
interventional
44
1 country
1
Brief Summary
The psychosocial needs of children with cancer and their families are well-documented in the literature, including the increased risk of parental posttraumatic stress, parental anxiety, and decreased family functioning. There is a critical need to provide evidence-based psychosocial care to parents of children with cancer, although many challenges exist with regard to in-person intervention delivery. eHealth interventions represent an exciting potential opportunity to address many of the barriers to in-person intervention delivery in this population, but are not yet widely utilized in pediatric psychosocial cancer care. eSCCIP is an innovative eHealth intervention for parents of children with cancer, delivered through a combination of self-guided interactive online content and telehealth follow-up with a therapist. eSCCIP aims to decrease symptoms of anxiety, distress, and posttraumatic stress while improving family functioning by delivering evidence-based therapeutic content through a flexible, easily accessible intervention tool. The four self-guided online modules feature a mix of didactic video content, novel multifamily video discussion groups featuring parents of children with cancer, and hands-on interactive activities. Preliminary Think Aloud testing has been completed and led to several rounds of design and functionality improvements. The objective of the proposed study is to establish feasibility and acceptability of eSCCIP in a diverse group of parents of children with cancer. A secondary, exploratory goal is to evaluate preliminary intervention effectiveness for key psychosocial outcomes. Specific Aim 1 is to identify strategies for increasing participant engagement and retention by conducting focus groups with a diverse sample of parents of children with cancer prior to pilot testing. Specific Aim 2 is to demonstrate the feasibility of eSCCIP through pilot testing with a diverse sample of parents of children with cancer. Specific Aim 3 is to evaluate preliminary effectiveness of eSCCIP through pilot testing with parents of children with cancer. The proposed study is an important first step in meeting a critical need for families of children with cancer and collecting data to power a randomized clinical trial to establish clinical efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2022
CompletedFirst Submitted
Initial submission to the registry
April 11, 2022
CompletedFirst Posted
Study publicly available on registry
April 19, 2022
CompletedResults Posted
Study results publicly available
October 19, 2022
CompletedJune 11, 2024
June 1, 2024
2.1 years
April 11, 2022
May 17, 2022
June 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The eSCCIP Evaluation Questionnaire
The eSCCIP Evaluation Questionnaire is a questionnaire designed to evaluate intervention acceptability, feasibility, and usability. Data is descriptive and examined at the item-level. Each item is scored on a 0-4 Likert scale (Not at all true - Very true). Mean score with standard deviation are reported at the item-level.
Up to 6 weeks.
Secondary Outcomes (5)
Distress Thermometer
Up to 9 weeks
Generalized Anxiety Disorder - 7 (GAD-7)
Up to 9 weeks
SCORE-15
Up to 9 weeks
PTSD Checklist for DSM-5 (PCL-5)
Up to 9 weeks.
The COVID-19 Exposure and Family Impact Scales (CEFIS)
Up to 9 weeks.
Study Arms (1)
eSCCIP
EXPERIMENTALThe Electronic Surviving Cancer Competently Intervention Program (eSCCIP) is an innovative eHealth intervention that combines cognitive behavioral and family systems therapy to provide parents and caregivers of children with cancer (PCCC) with evidence-based coping skills and psychosocial support focused on the family unit. eSCCIP has three 30-minute, self-directed, online modules which feature a unique mix of original video content and interactive activities, supplemented by three telehealth follow-up sessions. eSCCIP aims to reduce acute distress and symptoms of post-traumatic stress while increasing positive coping self-appraisal and use of cognitive coping skills.
Interventions
The Electronic Surviving Cancer Competently Intervention Program (eSCCIP) is an innovative eHealth intervention that combines cognitive behavioral and family systems therapy to provide parents and caregivers of children with cancer (PCCC) with evidence-based coping skills and psychosocial support focused on the family unit. eSCCIP has three 30-minute, self-directed, online modules which feature a unique mix of original video content and interactive activities, supplemented by three telehealth follow-up sessions. eSCCIP aims to reduce acute distress and symptoms of post-traumatic stress while increasing positive coping self-appraisal and use of cognitive coping skills.
Eligibility Criteria
You may qualify if:
- Participants must be the parent or primary caregiver of a child (ages 0 - 18 years old) diagnosed with cancer.
- Participants must be able to speak and read English.
- Participants must have access to the internet through a computer or mobile device (e.g., smartphone, tablet).
You may not qualify if:
- \- Potential participants are ineligible to participate if their child is not expected to live longer than six months from the time of potential recruitment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nemours Children's Health
Wilmington, Delaware, 19803, United States
MeSH Terms
Conditions
Results Point of Contact
- Title
- Dr. Kimberly Canter
- Organization
- Nemours Children's Health
Study Officials
- PRINCIPAL INVESTIGATOR
Kimberly Canter, PhD
Nemours Children's Health
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Research Scientist
Study Record Dates
First Submitted
April 11, 2022
First Posted
April 19, 2022
Study Start
January 1, 2020
Primary Completion
January 31, 2022
Study Completion
January 31, 2022
Last Updated
June 11, 2024
Results First Posted
October 19, 2022
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share